cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Cytek Biosciences Inc
2 own
2 watching
Current Price
$5.92
$-0.04
(-0.67%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
873.96M
52-Week High
52-Week High
12.31000
52-Week Low
52-Week Low
3.80000
Average Volume
Average Volume
0.42M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization873.96M
icon52-Week High12.31000
icon52-Week Low3.80000
iconAverage Volume0.42M
iconDividend Yield--
iconP/E Ratio--
What does the Cytek Biosciences Inc do?
Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells; and aurora cell sorter system, which leverages full spectrum profiling technology to further broaden potential applications across cell analysis. The company also provides reagents and kits, including cFluor reagents, which are fluorochrome conjugated antibodies used to identify cells of interest for analysis on its instruments, as well as 25-color immunoprofiling assay that provides turnkey solutions for identifying major human immune subpopulations for TBNK cells, monocytes, dendritic cells, and basophils. In addition, it offers automated micro-sampling system and automated sample loader system, which are automated plate loaders to integrate seamlessly into the aurora and northern lights systems; SpectroFlo software that provides intuitive workflow from quality control to data analysis for aurora and northern lights systems; and customer support tools. The company serves pharmaceutical and biopharma companies, academic research centers, and clinical research organizations. It distributes its products through direct sales force and support organizations in North America, Europe, China, and the Asia-Pacific region; and through distributors or sales agents in European, Latin American, the Middle Eastern, and the Asia-Pacific countries. The company was formerly known as Cytoville, Inc. and changed its name to Cytek Biosciences, Inc. in August 2015. Cytek Biosciences, Inc. was founded in 1992 and is headquartered in Fremont, California.
Read More
How much money does Cytek Biosciences Inc make?
News & Events about Cytek Biosciences Inc.
Zolmax
1 year ago
Cytek Biosciences, Inc. (NASDAQ:CTKB Get Rating) CEO Wenbin Jiang sold 20,000 shares of the stock in a transaction dated Monday, April 10th. The stock was sold at an average price of $8.88, for a total transaction of $177,600.00. Following the transaction, the chief executive officer now owns 7,684,...
Globe Newswire
1 year ago
SALUGGIA, Italy,and FREMONT, Calif., Feb. 28, 2023 (GLOBE NEWSWIRE) -- DiaSorin (FTSE MIB: DIA) and Cytek Biosciences, Inc. (Nasdaq: CTKB) today announced that Luminex Corporation, a wholly owned subsidiary of DiaSorin, has completed the sale of substantially all of its assets related to the Flow ...
Globe Newswire
1 year ago
New Agreement Enhances High-Parameter Panels on Cytek Cell Analysis SystemsFREMONT, Calif., Feb. 07, 2023 (GLOBE NEWSWIRE) -- Delivering a boost to immuno-oncology and immunotherapy researchers, Cytek Biosciences, Inc. (Nasdaq: CTKB) today announced that it has entered into a strategic partnership ...
Globe Newswire
1 year ago
New Digital Ecosystem Supports Full Spectrum Flow Cytometry Research from Panel Design to Data Acquisition Cytek Cloud Cytek Cloud is the new digital ecosystem that supports full spectrum flow cytometry research from panel design to data acquisition. FREMONT, Calif., Nov. 15, 2022 (GLOBE ...
Ticker Report
1 year ago
Cytek Biosciences, Inc. (NASDAQ:CTKB Get Rating) CFO Patrik Jeanmonod sold 3,500 shares of the businesss stock in a transaction dated Monday, October 24th. The stock was sold at an average price of $15.16, for a total value of $53,060.00. Following the sale, the chief financial ...
Frequently Asked Questions
Frequently Asked Questions
What is Cytek Biosciences Inc share price today?
plus_minus_icon
Can Indians buy Cytek Biosciences Inc shares?
plus_minus_icon
How can I buy Cytek Biosciences Inc shares from India?
plus_minus_icon
Can Fractional shares of Cytek Biosciences Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Cytek Biosciences Inc stocks?
plus_minus_icon
What is today’s traded volume of Cytek Biosciences Inc?
plus_minus_icon
What is today’s market capitalisation of Cytek Biosciences Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Cytek Biosciences Inc?
plus_minus_icon
What percentage is Cytek Biosciences Inc down from its 52-Week High?
plus_minus_icon
What percentage is Cytek Biosciences Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$5.92
$-0.04
(-0.67%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00